Inebilizumab for Treatment of IgG4-Related Disease - John H. Stone; Arezou Khosroshahi; Wen Zhang; Emanuel Della Torre; Kazuichi Okazaki; Yoshiya Tanaka; J. Matthias Löhr; Nicolas Schleinitz; Lingli Dong; Hisanori Umehara; Marco Lanzillotta; Zachary S. Wallace; et al. (New England Journal of Medicine, 2025)